2022
DOI: 10.1038/s41587-022-01230-4
|View full text |Cite
|
Sign up to set email alerts
|

Identification of antimicrobial peptides from the human gut microbiome using deep learning

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…We developed a new drug-drug network, which was the rst component of DLCDPS, the DDN of system used the critically acclaimed machine learning algorithm XGBoost 36 to learn drug-drug interaction in humans and mice based on drug features, which were collected from DrugBank. Hyperparameters for model prediction, such as learning rate, were selected by using 5-fold cross-validation of the training data, and the results showed that cross-validation 37 performance in drug-combination datasets collected from DrugBank (Supplementary Fig. 1a).…”
Section: Drug-drug Networkmentioning
confidence: 99%
“…We developed a new drug-drug network, which was the rst component of DLCDPS, the DDN of system used the critically acclaimed machine learning algorithm XGBoost 36 to learn drug-drug interaction in humans and mice based on drug features, which were collected from DrugBank. Hyperparameters for model prediction, such as learning rate, were selected by using 5-fold cross-validation of the training data, and the results showed that cross-validation 37 performance in drug-combination datasets collected from DrugBank (Supplementary Fig. 1a).…”
Section: Drug-drug Networkmentioning
confidence: 99%